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Background: Cytomegalovirus associated transverse myelitis among immunocompetent adults has been rarely
reported. We report a patient presenting with clinical myelitis followed by previously unreported finding of
cytomegalovirus deoxyribonucleic acid in cerebrospinal fluid.
Case report: A forty year old immunocompetent male presented with acute onset progressive bilateral lower limb
weakness. His spinal magnetic resonance imaging findings, cerebrospinal fluid analysis and clinical picture were
compatible with transverse myelitis. Polymerase chain reaction of the cerebrospinal fluid for cytomegalovirus was
positive while other infectious agents were not detected by serology or polymerase chain reaction. He was treated
with intravenous ganciclovir with partial clinical response.
Conclusion: Viral genome detection in the cerebrospinal fluid was performed but negative in five out of ten
reported cases of cytomegalovirus associated transverse myelitis in the immunocompetent host. In previous cases
the inability to isolate the virus in cerebrospinal fluid was considered favouring an immunological mechanism
leading to pathogenesis rather than direct viral toxicity but this case is against that theory. This case highlights the
fact that Cytomegalovirus should be considered as an aetiological agent in patients with transverse myelitis and
that the virus may cause serious infections in immunocompetent host. Therefore this report is of importance to
neurologists and physicians in general.
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Hyper intensityBackground
Cytomegalovirus is member of the herpesviridae family
and usually causes asymptomatic infections. It remains
latent and may reactivate when the host has poor im-
mune responses leading to life threatening infection.
Cytomegalovirus (CMV) is a known cause of severe cen-
tral nervous system (CNS) infection among immunosup-
pressed patients especially among those infected with
human immunodeficiency virus. CNS infections reported
in the immunocompetent hosts due to CMV include en-
cephalitis, meningitis, myelitis and the combinations of
any of the above [1]. Although randomized trials are lack-
ing, physicians generally tend to use antiviral treatment* Correspondence: suneth871@gmail.com
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distribution, and reproduction in any mediumincluding ganciclovir and valganciclovir for severe CMV
infections. Use of polymerase chain reaction of CSF for
CMV has been reccommended for diagnosis of CNS in-
fection [2].
Acute transverse myelitis is a focal inflammatory disorder
of the spinal cord with sensory, motor and autonomic dys-
function [3]. Cytomegalovirus has been described rarely as
a aetiological agent in immunocompetent adults present-
ing with transverse myelitis with only ten cases described
previously [4-13]. Infact, any form of severe infection
with cytomegalovirus is rare [14]. Out of the ten, only
five cases describe abnormalities in the magnetic reson-
ance imaging (MRI) of spinal cord in CMV associated
transverse myelitis (Table 1). Two reports describe con-
firmation of CMV infection with detection of CMV de-
oxyribonucleic acid (DNA) in the serum by polymeraseentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 The comparison of CSF analysis, MRI appearance, CMV serology and PCR of reported cases of CMV associated











CSF PCR Blood PCR MRI findings
Our Patient (2011) 300 350 (L-92%) Negative Negative Positive ND T1 mild swelling (C2-C5)
T2 hyperintensity
No contrast enhancement
1 (2006) Ben Abdelhafidh N 430 15 (L-80%) Positive ND Negative Negative T1 hypointensity
T2 hyperintensity
No contrast enhancement
2 (2005) Rigamonti A 370 11 (L-85%) Positive Positive Negative Negative T1 signal abnormality
T2 hyperintensity
Contrast enhancement
3 (2003) Fux CA 480 29 (M-95%) Positive Negative Negative CMV Antigen positive Negative
4 (2002) Karacostas D 150 0 Positive Positive Negative Positive T1 Normal
T2 hyperintensity
No contrast enhancement
5 (1999) Giobbia M 1240 3(L-100%) Positive negative Negative positive T2 hyperintensity
6 (1995) Baig SM 1650 230(M-95%) Positive ND ND ND Negative
7 (1993) Miles C 1700 200(PMN-62%) Positive ND ND ND Negative
8 (1993) Tobita M 1020 104 Positive Positive ND ND T2 hyperintensity
9 (1986) Tyler KL 1400 226 (M-76%) Positive ND ND ND ND
10(1976) Kabins S 7200 3200 (PMN-100%) Positive ND ND ND ND
ND-not done.
Majority of the case show CSF pleocytosis with lymphocyte predominance and T 2 signal hyper intensity in the MRI.
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firmed CMV antigenaemia. There were no reported
cases of CMV PCR positivity in cerebrospinal fluid. We
describe a immunocompetent adult who had clinical
features, neuroimaging findings and CSF analysis com-
patible with transverse myelitis where CMV DNA was
detected in CSF.
Transverse myelitis diagnosis criteria
Bilateral (not necessarily symmetric) sensorimotor and
autonomic spinal cord dysfunction
Clearly defined sensory level
Progression to nadir of clinical deficits between 4 hours
and 21 days after symptom onset
Demonstration of spinal cord inflammation:
cerebrospinal fluid pleocytosis or elevated IgG index, or
MRI revealing a gadolinium-enhancing cord lesion
Exclusion of compressive, postradiation, neoplastic, and
vascular causesCase presentation
A forty year old previously healthy Sri Lankan male
presented with acute onset bilateral leg weakness which
was progressive over two days following a brief febrile
illness of three days. He did not give any history of
trauma nor there was any history of tuberculosis. Ini-
tially he did not have urinary retention nor there was
any sensory symptoms. He did not complain of short-
ness of breathing.
On examination he was found to have asymmetric
flaccid paralysis of bilateral lower limbs with power
grade one to two. Reflexes were diminished bilaterally
and Babinski sign was equivocal. Examination of optic
fundi and cranial nerves were normal. There was no
demonstrable sensory level and joint position sense was
initially preserved. Upper limbs were neurologically nor-
mal. Respiratory movements and sphincter function
were preserved. Depending on initial findings a clinical
diagnosis of Guillain-Barré syndrome was suspected and
he was closely observed for the development of respira-
tory paralysis with monitoring of forced vital capacity
and oxygen saturation.
On the fifth day of onset of symptoms his weakness
worsened with additional flaccid paralysis of upper
Figure 2 T1 weighted image showing mild swelling of mid
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retention of urine. Patient was urgently transferred to
a high dependency unit but he did not develop re-
spiratory paralysis necessitating ventilator support.
Later he developed bilateral spastic paraparesis and
positive Babinski sign with mild paraesthesia of lower
limbs. But he did not develop a definite sensory level
at anytime during the course of his illness.
A nerve conduction study failed to show demyelin-
ation or axonal loss. Magnetic resonance imaging study
of the spine showed hyperintensity of central portion of
mid cervical cord from C 2 to C 5 level in T2 weighted
and FLAIR images (Figure 1) There was mild swelling of
cervical cord without significant change of signal inten-
sity on T1 weighted image (Figure 2).
Basic investigations were as follows; Na+ 139 mmol/l,
K+-4.2 mmol/l, Serum creatinine-62 μmol/l, blood urea
8.7 mmol/l, White cell count 5000/mm3(N-76,L-18),
platelet count 17500/mm3. Haemoglobin 9.3 g/dl, AST-
51u/l, ALT-74u/l, Bilirubin 12 μmol/l, ESR-12 mm/hr,
CRP-0.4 mg/dl, VDRL-negative, Fasting blood sugar
5.4 mmol/l.
Cerebrospinal fluid analysis done on the tenth day after
onset of weakness was suggestive of a viral CNS infectionFigure 1 T2 weighted image showing hyperintensity of the
central portion of the mid cervical cord (arrow).
cervical cord (arrow).with a protein content of 300 mg/l, glcose 4.3 mmol/l
(RBS 10.9 mmol/l) and a leukocyte count of 350/mm3
(92% lymphocytes). CSF infectious screen was positive for
cytomegalovirus PCR(sensitivity more than 100copies/ml).
This test was repeated and result was confirmed. Cyto-
megalovirus IgG and IgM were not detected in CSF. Poly-
merase chain reaction of CSF for herpes simplex virus
(HSV) and Japanese encephalitis virus(JEV) were negative.
Oligoclonal bands were not detected in CSF.
Considering the overall clinical picture, a working
diagnosis of CMV associated transverse myelitis was
made. Immunoglobulin levels and lymphocyte subset
analysis failed to identify any immunodeficiency while
HIV serology was negative.
Patient received treatment with intravenous ganciclo-
vir for a duration of 21 days starting on the 10th day of
illness. He was also given maximal supportive care with
physiotherapy and psychological support. A second CSF
analysis done 22 days after the onset of symptoms
revealed no cells and protein content of 390 mg/l. (CSF
glucose 3.6 mmol/l RBS-6.5 mmol/l) Repeated CMV
serology in blood, CSF and CSF PCR for CMV were
negative on the 22nd day of illness.
One month after the onset of symptoms the upper
limb power was improved (grade 5) but the lower limb
power remained grade 3. He was transferred to a long
term rehabilitation facility.
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The findings in our patient are suggestive of acute
transverse myelitis involving spinal segments C3 to
C5. According to the proposed diagnosis criteria for
Transverse myelitis [3] our patient had evidence of
spinal cord inflammation evidenced by CSF pleocytosis
and MRI appearance. Although a clear sensory level
was absent, he had sensory, motor and autonomic dys-
function attributable to the spinal cord, bilateral in-
volvement, progression to nadir between 4 hours to
21 days after symptom onset and absence of compres-
sive lesions.
Patient’s clinical history was compatible with acute
cytomegalovirus infection. Polymerase chain reaction
has been found to be the most reliable method for the
CMV related CNS infections [6]. While cytomegalovirus
is an identified cause of myelitis in immunocomprom-
ised hosts, it is rare in the immunocompetent people
with only few published case reports. (Table 1) Cyto-
megalovirus PCR has demonstrated the presence of
CMV DNA in blood in only two reported cases of CMV
associated transverse myelitis in the immunocompetent
patients [7,8]. In other immunocompetent patients with
CMV transverse myelitis, either PCR was not done or
was negative. All ten patients had positive serology for
CMV antibody while in this patient serology was
negative.
Five patients had their CSF tested for CMV DNA by
PCR and all were negative. Therefore our patient is the
first reported case of CMV DNA positivity in CSF
among all immunocompetent patients with CMV trans-
verse myelitis. Absence of CMV DNA in CSF in previ-
ous cases has been considered to favour immune
mediated rather than direct virus induced injury to the
cord [5,6]. The presence of CMV DNA in CSF while ser-
ology remained negative may indicate direct virus
induced injury has to be considered in the pathogenesis
of CMV transverse myelitis. The reason for negativity of
CMV antibodies in our patient could be either due to
low sensitivity of the serological test or early treatment
leading to destruction of virus before an immunological
response is mounted.
Out of the ten patients MRI findings were abnormal
in five patients, while others either had normal MRI
appearances or MRI was not performed. Commonest
MRI finding was signal hyperintensity in T2 sequences.
Other documented MRI findings include T1 hypointen-
sity as well as hyper intensity. Contrast enhancement
of the spinal cord was documented only in a single
case report [5].
This case emphasizes the fact that CMV should be
considered as an aetiological agent in patients present-
ing with a clinical syndrome suggestive of transverse
myelitis even though they are immunocompetent.Cytomegalovirus DNA detection in CSF and MRI ap-
pearance can help in the diagnosis of CMV transverse
myelitis. Although randomised trials are lacking, ganci-
clovir can be useful in the management of CMV trans-
verse myelitis.
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